Arrowhead Pharmaceuticals Corp (ARWR) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.00 +0.22%
Revenue Growth %: +89.5%
Financial Fact:
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES: -19.42M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +89.5%
Financial Fact:
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES: -19.42M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Corp (NASDAQ: ARWR) reported Q1 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.51 million versus the consensus estimate of $7.27 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Corp (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- MP Materials seen largely insulated after China export-control move
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
